Viewing Study NCT04148118


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-03-03 @ 6:44 PM
Study NCT ID: NCT04148118
Status: COMPLETED
Last Update Posted: 2022-05-18
First Post: 2019-10-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults
Sponsor: BlueWillow Biologics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anthrax View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anthrax View
None Nanoemulsion adjuvant View
None Nasal Vaccine View
None Recombinant Protective Antigen View